Teladoc Health Inc. [NYSE: TDOC] surged by $4.74 during the normal trading session on Tuesday and reaching a high of $148.51 during the day while it closed the day at $145.79. The company report on May 11, 2021 that Teladoc Health Launches “myStrength Complete” As First Unified Mental Health Care Experience.
New Consumer Study Reinforces Impact of Comprehensive Virtual Mental Health Care.
Teladoc Health, Inc. (NYSE: TDOC) announced the launch of myStrength Complete, an integrated mental health service providing personalized, targeted care to consumers in a single, comprehensive experience. The announcement comes as more than half of people with mental health concerns report that they do not know where to start when getting care, highlighting the importance of the digital front door myStrength Complete will provide.
Teladoc Health Inc. stock has also loss -7.94% of its value over the past 7 days. However, TDOC stock has declined by -49.47% in the 3 months of the year. Over the past six months meanwhile, it has lost -29.28% and lost -27.09% year-on date.
The market cap for TDOC stock reached $22.66 billion, with 152.17 million shares outstanding and 135.93 million shares in the current float. Compared to the average trading volume of 3.78M shares, TDOC reached a trading volume of 6346482 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Teladoc Health Inc. [TDOC]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for TDOC shares is $238.24 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on TDOC stock is a recommendation set at 2.20. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Needham have made an estimate for Teladoc Health Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on April 15, 2021. While these analysts kept the previous recommendation, BTIG Research raised their target price to Buy. The new note on the price target was released on January 07, 2021, representing the official price target for Teladoc Health Inc. stock. Previously, the target price had yet another raise to $215, while Evercore ISI analysts kept a In-line rating on TDOC stock. On December 07, 2020, analysts decreased their price target for TDOC shares from 270 to 210.
The Average True Range (ATR) for Teladoc Health Inc. is set at 8.56, with the Price to Sales ratio for TDOC stock in the period of the last 12 months amounting to 16.58. The Price to Book ratio for the last quarter was 1.40, with the Price to Cash per share for the same quarter was set at 4.65.
TDOC stock trade performance evaluation
Teladoc Health Inc. [TDOC] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -7.94. With this latest performance, TDOC shares dropped by -19.90% in over the last four-week period, additionally sinking by -29.28% over the last 6 months – not to mention a drop of -23.52% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TDOC stock in for the last two-week period is set at 28.28, with the RSI for the last a single of trading hit 24.68, and the three-weeks RSI is set at 31.73 for Teladoc Health Inc. [TDOC]. The present Moving Average for the last 50 days of trading for this stock 181.94, while it was recorded at 149.35 for the last single week of trading, and 209.56 for the last 200 days.
Teladoc Health Inc. [TDOC]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Teladoc Health Inc. [TDOC] shares currently have an operating margin of -37.42 and a Gross Margin at +57.92. Teladoc Health Inc.’s Net Margin is presently recorded at -44.35.
Return on Total Capital for TDOC is now -4.34, given the latest momentum, and Return on Invested Capital for the company is -5.16. Return on Equity for this stock declined to -5.74, with Return on Assets sitting at -4.86. When it comes to the capital structure of this company, Teladoc Health Inc. [TDOC] has a Total Debt to Total Equity ratio set at 9.30. Additionally, TDOC Total Debt to Total Capital is recorded at 8.51, with Total Debt to Total Assets ending up at 8.07. Long-Term Debt to Equity for the company is recorded at 8.96, with the Long-Term Debt to Total Capital now at 8.20.
Reflecting on the efficiency of the workforce at the company, Teladoc Health Inc. [TDOC] managed to generate an average of -$110,258 per employee. Receivables Turnover for the company is 9.67 with a Total Asset Turnover recorded at a value of 0.11.Teladoc Health Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.70 and a Current Ratio set at 4.00.
Earnings per share (EPS) analysis for Teladoc Health Inc. [TDOC] stock
With the latest financial reports released by the company, Teladoc Health Inc. posted -0.34/share EPS, while the average EPS was predicted by analysts to be reported at -0.23/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -47.80%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for TDOC. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Teladoc Health Inc. go to -3.13%.
Teladoc Health Inc. [TDOC]: Insider Ownership positions
There are presently around $17,022 million, or 76.70% of TDOC stock, in the hands of institutional investors. The top three institutional holders of TDOC stocks are: VANGUARD GROUP INC with ownership of 11,473,659, which is approximately 11.23% of the company’s market cap and around 0.70% of the total institutional ownership; BLACKROCK INC., holding 8,822,870 shares of the stock with an approximate value of $1.29 billion in TDOC stocks shares; and GENERAL CATALYST GROUP MANAGEMENT, LLC, currently with $1.17 billion in TDOC stock with ownership of nearly New of the company’s market capitalization.
Positions in Teladoc Health Inc. stocks held by institutional investors increased at the end of April and at the time of the April reporting period, where 489 institutional holders increased their position in Teladoc Health Inc. [NYSE:TDOC] by around 28,644,628 shares. Additionally, 453 investors decreased positions by around 20,123,406 shares, while 105 investors held positions by with 67,986,393 shares. The mentioned changes placed institutional holdings at 116,754,427 shares, according to the latest SEC report filing. TDOC stock had 141 new institutional investments in for a total of 8,958,872 shares, while 165 institutional investors sold positions of 7,220,796 shares during the same period.